Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
- Abstract
- Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma:a multicenter, retrospective analysis
- Issued Date
- 2021
- Type
- Article
- Keyword
- Adenine / analogs & derivatives; Adult; Humans; Lymphoma; Mantle-Cell* / drug therapy; Neoplasm Recurrence; Local; Piperidines; Republic of Korea; Retrospective Studies
- URI
- http://oak.ulsan.ac.kr/handle/2021.oak/7921
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_doaj_primary_oai_doaj_org_article_5d08eb39eacb428a89867494569557f4&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,Real-world%20outcomes%20of%20ibrutinib%20therapy%20in%20Korean%20patients%20with%20relapsed%20or%20refractory%20mantle%20cell%20lymphoma:%20a%20multicenter,%20retrospective%20analysis&offset=0&pcAvailability=true
- Publisher
- Cancer Communications
- Location
- 영국
- Language
- 영어
- ISSN
- 2523-3548
- Citation Volume
- 41
- Citation Number
- 3
- Citation Start Page
- 275
- Citation End Page
- 278
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.